Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging - Wikidata - awgldk - TriplyDB

Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging

Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging

http://www.wikidata.org/entity/Q35227508

about

Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.Prospective Study of (68)Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients.[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts.Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixafor.[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values.Al[18F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 Expression.FDG-PET imaging in hematological malignancies PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients.Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.Molecular imaging probes derived from natural peptides.An Ultra-High Fluorescence Enhancement and High Throughput Assay for Revealing Expression and Internalization of Chemokine Receptor CXCR4.The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity.Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.[177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent.(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.New Perspectives Offered by Nuclear Medicine for the Imaging and Therapy of Multiple Myeloma.[68Ga]pentixafor for CXCR4 imaging in a PC-3 prostate cancer xenograft model - comparison with [18F]FDG PET/CT, MRI and ex vivo receptor expression.Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET.Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics.Targeting CXCR4 with [68Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?[68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques.PET Molecular Targets and Near-Infrared Fluorescence Imaging of Atherosclerosis.[Hemato-oncological imaging : Importance of hybrid procedures].Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.Upregulated myocardial CXCR4-expression after myocardial infarction assessed by simultaneous GA-68 pentixafor PET/MRI.Prospective of 68Ga Radionuclide Contribution to the Development of Imaging Agents for Infection and Inflammation.Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment.PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma CXCR4-directed theranostics in oncology and inflammation

P2860

Q30491728-D63FF0D6-C880-455E-97A1-3C0D18897805 Q33703097-0961A7DF-193C-4485-858C-6F5B24070282 Q33758646-E4A69D53-3193-47E1-949E-3816B85BE805 Q35483867-BF461FE3-D19D-40D7-9729-A1417D5F1049 Q35633357-FBE24F25-3D82-4740-AE6A-9E88BA73B6A8 Q36962582-F8AF1623-6094-4797-9B7A-6AE85643D46A Q37022167-FCCB97C2-E0E7-458B-930C-2D73958E4A92 Q37140477-2960EFCD-5B01-4E2A-BBDE-A0631096957B Q37273212-8ECF0B6B-C81F-4916-97EA-9E45318EA7BE Q37541868-98687061-0557-42F2-BB4F-FE858580DDBC Q37592059-E379D1F5-46CF-4473-91DB-BD5E85743D14 Q37632114-D17303B6-2E5A-4645-9627-F487147F1530 Q37691050-473B45CA-259D-4FDE-900C-98C4DAD2ED9E Q38612027-B799DB7D-8D32-4549-A84B-2D08A063C0DF Q38748846-928C5326-951D-4FCD-856C-517360B8F093 Q38794040-39D08035-52EE-4BC6-B6DF-344023EF0A7A Q38876206-7B9E48FF-4170-4D7B-BEC5-CC7CA674D3CD Q39470633-54BE2E1F-9F50-464F-9C9E-F094D437FD65 Q41114242-D7C67B69-64B0-43CB-A152-A9D3577CAF3C Q42545669-5CC51933-5F74-43B0-A3E7-783486F6E516 Q43065347-A4E4A601-75D5-4422-8BB2-6FD9FF2A93E7 Q47099762-D1A22912-F67A-44D8-B471-160435F10B94 Q47100529-6CABEA1C-8D0A-4AD9-9E8C-8131CCB64893 Q47114899-59953BFF-ED3A-4D8F-834E-4E42B198BC7A Q47159998-9F172ACC-22A7-4135-A6DE-E3409C32F6C2 Q48317785-53EE954C-276B-4FC9-AD6D-FF32F12E0E50 Q50051033-63B67399-75A4-4C04-8CE1-57D3643920C9 Q52982170-57611A5C-996A-4609-977E-B54B32A8D34B Q52983236-6C4916B6-D549-4FC5-B84B-84871D249F0E Q52986842-55B0B439-A3E5-469A-AED1-BE7B44839157 Q54257268-5CEE7DB9-A28D-43C0-B13B-F9EBC3B4469B Q55000995-DC6BAC66-D905-474E-B325-F8DDD41A6BF7 Q57160039-07B07708-9BF1-40F1-B920-6D6660955136 Q58783862-8537745B-B5E1-4980-98FA-85F2FC7EDADD

P2860

Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging

http://www.wikidata.org/entity/Q35227508

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Disclosing the CXCR4 expressio ...... by targeted molecular imaging

@ast

Disclosing the CXCR4 expressio ...... by targeted molecular imaging

@en

type

label

Disclosing the CXCR4 expressio ...... by targeted molecular imaging

@ast

Disclosing the CXCR4 expressio ...... by targeted molecular imaging

@en

prefLabel

Disclosing the CXCR4 expressio ...... by targeted molecular imaging

@ast

Disclosing the CXCR4 expressio ...... by targeted molecular imaging

@en

P1433

Q35227508-BEC88F99-3602-421D-86C2-A58BEF86F139

P1476

Q35227508-471D7495-58A2-4A83-B54D-6AFA06A31E96

P2093

Q35227508-2308D506-25E1-4A64-83DF-04364C86D3CC

Q35227508-7771EA62-6747-482E-B1C7-686E3BA8CD17

Q35227508-78E10F67-657D-499C-B8A5-8ADB311FD3D0

Q35227508-A4781722-5B29-4832-83C4-A5AFF0C34BD1

Q35227508-ACBA5413-F5CA-4B15-9D3C-B9B73E05DCDE

Q35227508-B20958BA-32D8-4CC7-A85E-65670EB3EAE9

Q35227508-BB3EF73F-6745-4F12-8DE2-8112AC3CCD95

Q35227508-CA018F73-75D2-434F-8A63-7D08F26964A5

Q35227508-CE4D94F6-9C32-4F39-AAD9-947449234451

Q35227508-D673D1DA-73B2-4746-8112-2C137FC72811

P2860

Q35227508-00260286-8BCE-436E-BA08-5E3945D120FF

Q35227508-00524D4A-235F-4426-A7A4-381FDD5F173C

Q35227508-01B2D0EB-F124-4D75-A7C7-E661B19E267A

Q35227508-02303F04-36B8-4844-A97A-1122620A9487

Q35227508-0266ABD2-4183-4DD5-8AF0-81DCBDD1983B

Q35227508-0703738F-DF67-40AA-AC60-86D6ABA7F0E0

Q35227508-097D662D-2E38-4E06-81E9-012A66C0B743

Q35227508-0ABD69C1-4255-4990-B7A8-F25B9AFB6F0B

Q35227508-0E875CA2-2290-42AB-8AD0-6F718B940637

Q35227508-103F829A-B644-4912-8317-EEFC032DEF9E

P304

Q35227508-798DCD5B-C70B-42E1-A7CC-5E39DE72B9E3

P31

Q35227508-731A5ECD-9C46-47C7-978F-C408AC2758E8

P356

Q35227508-8DA9C4B0-3D22-4D7D-84BA-AA6AEF850CBB

P433

Q35227508-F2146266-2658-42DD-9B27-01AD23754738

P478

Q35227508-7249E7BC-E027-4601-8171-CA16671489EF

P50

Q35227508-54F4EFE2-D79C-4FA2-BC3B-8F5688DB94FF

Q35227508-B781B5EE-8B04-4F18-8783-EF964D69B9BF

Q35227508-DC3EE477-AC9E-46BA-8828-FB28C9BC094E

P577

Q35227508-FCC7B025-BE0F-446A-A1A3-428DA3F1806F

P5875

Q35227508-BB1D240A-EFA0-495F-AC6F-AB168DD4D889

P698

Q35227508-45336576-77FE-4BA2-BC11-5A6589F797BA

P932

Q35227508-A3631FAF-1911-49F4-929D-1E668DED9C2F

P356

P1433

P1476

Disclosing the CXCR4 expressio ...... by targeted molecular imaging

@en

P2093

Ambros Beer

http://www.w3.org/2001/XMLSchema#string

Carlos Gerngross

http://www.w3.org/2001/XMLSchema#string

Frauke Hoffmann

http://www.w3.org/2001/XMLSchema#string

Hans Jürgen Wester

http://www.w3.org/2001/XMLSchema#string

Horst Kessler

http://www.w3.org/2001/XMLSchema#string

Jakub Šimeček

http://www.w3.org/2001/XMLSchema#string

Kathrin Philipp-Abbrederis

http://www.w3.org/2001/XMLSchema#string

Ken Herrmann

http://www.w3.org/2001/XMLSchema#string

Margret Schottelius

http://www.w3.org/2001/XMLSchema#string

Martina Rudelius

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of chemokine receptors in breast cancer metastasis

Development of a unique small molecule modulator of CXCR4

Targeted non-covalent self-assembled nanoparticles based on human serum albumin.

Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100

Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes.

FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation.

Design considerations of iron-based nanoclusters for noninvasive tracking of mesenchymal stem cell homing

Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography

Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)

Zn(II)-bis(cyclen) complexes and the imaging of apoptosis/necrosis.

P304

618-630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO.11251

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Michael Lassmann

Natalia S. Pellegata

Markus Schwaiger

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273887191

http://www.w3.org/2001/XMLSchema#string

P698

25825601

http://www.w3.org/2001/XMLSchema#string

P932

4377730

http://www.w3.org/2001/XMLSchema#string